• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院的 SARS-CoV-2 感染患者病毒 RNA 持续脱落的决定因素。

Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection.

机构信息

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

出版信息

Diagn Microbiol Infect Dis. 2021 Jun;100(2):115347. doi: 10.1016/j.diagmicrobio.2021.115347. Epub 2021 Feb 12.

DOI:10.1016/j.diagmicrobio.2021.115347
PMID:33639375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7879029/
Abstract

OBJECTIVE

To evaluate determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection.

MATERIALS AND METHODS

Hospitalized patients with SARS-CoV-2 positive nasopharyngeal RT-PCR were included in a single-center, retrospective study. Patients were divided in 2 groups according to the timing of viral clearance [≤14 days, "early clearance (EC)" and >14 days, "late clearance (LC)"].

RESULTS

179 patients were included in the study (101 EC, 78 LC), with median age 62 years. Median time of viral shedding was 14 days (EC/LC 10 and 19 days, respectively, P < 0.0001). Univariate analyses showed that age, male gender, receiving corticosteroids, receiving tocilizumab, ICU admission, low albumin and NLR ratio were associated with late viral clearance. In the multivariable analysis, older age (P = 0.016), albumin level (P = 0.048), corticosteroids (P = 0.021), and tocilizumab (P = 0.015) were significantly associated with late viral clearance.

CONCLUSIONS

Age, albumin, tocilizumab and corticosteroid treatment were independently associated with a prolonged SARS-CoV-2 RNA shedding.

摘要

目的

评估住院 SARS-CoV-2 感染患者病毒 RNA 延长脱落的决定因素。

材料和方法

纳入了一项单中心、回顾性研究中的 SARS-CoV-2 鼻咽 RT-PCR 阳性的住院患者。根据病毒清除的时间(≤14 天,“早期清除(EC)”和>14 天,“晚期清除(LC)”)将患者分为两组。

结果

研究纳入了 179 例患者(101 例 EC,78 例 LC),中位年龄为 62 岁。病毒脱落的中位时间为 14 天(EC/LC 分别为 10 天和 19 天,P < 0.0001)。单因素分析显示,年龄、男性、使用皮质类固醇、使用托珠单抗、入住 ICU、低白蛋白和 NLR 比值与晚期病毒清除有关。多变量分析显示,年龄较大(P = 0.016)、白蛋白水平较低(P = 0.048)、皮质类固醇(P = 0.021)和托珠单抗(P = 0.015)与晚期病毒清除显著相关。

结论

年龄、白蛋白、托珠单抗和皮质类固醇治疗与 SARS-CoV-2 RNA 延长脱落独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fad/7879029/9caee300914d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fad/7879029/9caee300914d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fad/7879029/9caee300914d/gr1_lrg.jpg

相似文献

1
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection.住院的 SARS-CoV-2 感染患者病毒 RNA 持续脱落的决定因素。
Diagn Microbiol Infect Dis. 2021 Jun;100(2):115347. doi: 10.1016/j.diagmicrobio.2021.115347. Epub 2021 Feb 12.
2
Clinical predictors and RT-PCR profile of prolonged viral shedding in patients with SARS-CoV-2 Omicron variant in Shanghai: A retrospective observational study.上海 SARS-CoV-2 奥密克戎变异株患者病毒持续排出的临床预测因素和 RT-PCR 特征:一项回顾性观察研究。
Front Public Health. 2022 Oct 24;10:1015811. doi: 10.3389/fpubh.2022.1015811. eCollection 2022.
3
Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.COVID-19 患者中 SARS-CoV-2 病毒持续排出与阿比多尔治疗开始延迟和就诊时间推迟有关:一项回顾性队列研究。
Curr Med Sci. 2021 Dec;41(6):1096-1104. doi: 10.1007/s11596-021-2434-y. Epub 2021 Sep 13.
4
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病(COVID-19)患者病毒RNA长期脱落的相关因素
Clin Infect Dis. 2020 Jul 28;71(15):799-806. doi: 10.1093/cid/ciaa351.
5
Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2.与感染奥密克戎 BA.2.2 的老年患者病毒持续排出相关的因素。
Front Public Health. 2023 Jan 12;10:1087800. doi: 10.3389/fpubh.2022.1087800. eCollection 2022.
6
Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.与 SARS-CoV-2 感染住院非重症患者病毒持续排出相关因素及洛匹那韦/利托那韦治疗的影响。
Eur Respir J. 2020 Jul 16;56(1). doi: 10.1183/13993003.00799-2020. Print 2020 Jul.
7
Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.糖尿病是危重症患者下呼吸道样本中 SARS-CoV-2 病毒持续脱落的一个风险因素。
Endocrine. 2020 Dec;70(3):454-460. doi: 10.1007/s12020-020-02465-4. Epub 2020 Sep 1.
8
Chronic rhinosinusitis is associated with prolonged SARS-CoV-2 RNA shedding in upper respiratory tract samples: A case-control study.慢性鼻-鼻窦炎与上呼吸道样本中 SARS-CoV-2 RNA 持续脱落相关:一项病例对照研究。
J Intern Med. 2021 Jun;289(6):921-925. doi: 10.1111/joim.13237. Epub 2021 Feb 9.
9
Prolonged viral shedding of SARS-CoV-2 and related factors in symptomatic COVID-19 patients: a prospective study.对有症状 COVID-19 患者中 SARS-CoV-2 的持续病毒脱落及其相关因素的前瞻性研究。
BMC Infect Dis. 2021 Dec 27;21(1):1282. doi: 10.1186/s12879-021-07002-w.
10
Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.SARS-CoV-2 RNA 脱落持续时间及 COVID-19 患者病毒脱落时间延长的相关因素。
J Med Virol. 2021 Jan;93(1):506-512. doi: 10.1002/jmv.26280. Epub 2020 Jul 15.

引用本文的文献

1
Prediction and phenotyping of long COVID in kidney transplant recipients: A cross-sectional study.肾移植受者中长新冠的预测与表型分析:一项横断面研究。
Clin Nephrol. 2025 Jun;103(6):366-376. doi: 10.5414/CN111584.
2
A retrospective analysis of the influencing factors of nucleic acid CT value fluctuation in COVID-19 patients infected with Omicron variant virus in Changchun city.长春市感染奥密克戎变异株的新冠病毒患者核酸 CT 值波动影响因素的回顾性分析。
Front Public Health. 2024 Jun 14;12:1377135. doi: 10.3389/fpubh.2024.1377135. eCollection 2024.
3
Influence of vaccination on critical COVID-19 patients with acute respiratory failure: a retrospective cohort study.

本文引用的文献

1
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.SARS-CoV-2、SARS-CoV 和 MERS-CoV 的病毒载量动态、病毒脱落持续时间和传染性:系统评价和荟萃分析。
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
2
Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).COVID-19 住院患者中感染性病毒排出的持续时间和关键决定因素。
Nat Commun. 2021 Jan 11;12(1):267. doi: 10.1038/s41467-020-20568-4.
3
Dexamethasone in Hospitalized Patients with Covid-19.
接种疫苗对急性呼吸衰竭的危重症 COVID-19 患者的影响:一项回顾性队列研究。
Eur J Med Res. 2024 Apr 20;29(1):243. doi: 10.1186/s40001-024-01840-5.
4
The Clinical Value of Systemic Immune Inflammation Index (SII) in Predicting the Severity of Hospitalized Children with Mycoplasma Pneumoniae Pneumonia: A Retrospective Study.全身免疫炎症指数(SII)在预测住院支原体肺炎患儿病情严重程度中的临床价值:一项回顾性研究
Int J Gen Med. 2024 Mar 12;17:935-942. doi: 10.2147/IJGM.S451466. eCollection 2024.
5
Association of clinical characteristics and vaccines with risk of persistently viral clearance in patients infected with SARS-CoV-2 Omicron variant in Shanghai, China.中国上海感染新冠病毒奥密克戎变异株患者的临床特征和疫苗与病毒持续清除风险的关联
Heliyon. 2023 Dec 8;10(1):e23256. doi: 10.1016/j.heliyon.2023.e23256. eCollection 2024 Jan 15.
6
Analysis of the effect of cytomegalovirus infection in clinical outcomes and prolonged duration of SARS-CoV-2 shedding in intensive care unit patients with COVID-19 pneumonia.分析巨细胞病毒感染对 COVID-19 肺炎重症监护病房患者临床结局和 SARS-CoV-2 脱落时间延长的影响。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231209150. doi: 10.1177/17534666231209150.
7
Development and external validation of a prognostic tool for nonsevere COVID-19 inpatients.开发并验证一种针对非重症 COVID-19 住院患者的预后工具。
Epidemiol Infect. 2023 May 19;151:e128. doi: 10.1017/S0950268823000717.
8
Different effects of vaccine on VST in critical and non-critical COVID-19 patients: A retrospective study of 363 cases.疫苗对重症和非重症COVID-19患者疫苗特异性T细胞的不同影响:一项363例病例的回顾性研究
Heliyon. 2023 May;9(5):e16017. doi: 10.1016/j.heliyon.2023.e16017. Epub 2023 May 1.
9
IL-6 and cfDNA monitoring throughout COVID-19 hospitalization are accurate markers of its outcomes.IL-6 和 cfDNA 监测贯穿 COVID-19 住院期间,是其预后的准确标志物。
Respir Res. 2023 May 5;24(1):125. doi: 10.1186/s12931-023-02426-1.
10
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study.接种疫苗和单克隆抗体后血液系统恶性肿瘤 COVID-19 患者的结局:HM-COV 2.0 研究结果。
Clin Exp Med. 2023 Oct;23(6):2275-2285. doi: 10.1007/s10238-023-01027-y. Epub 2023 Mar 3.
地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
4
Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.严重急性呼吸综合征冠状病毒 2 感染患者长期病毒排出的临床特征及相关因素:一项单中心 28 天研究。
J Infect Dis. 2020 Aug 17;222(6):910-918. doi: 10.1093/infdis/jiaa388.
5
Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.新型冠状病毒肺炎成年住院患者痰液与鼻咽拭子标本中 2019 年冠状病毒脱落持续时间的差异。
Chest. 2020 Nov;158(5):1876-1884. doi: 10.1016/j.chest.2020.06.015. Epub 2020 Jun 20.
6
Is Albumin Predictor of Mortality in COVID-19?白蛋白是新冠病毒肺炎患者死亡率的预测指标吗?
Antioxid Redox Signal. 2021 Jul 10;35(2):139-142. doi: 10.1089/ars.2020.8142. Epub 2020 Jun 22.
7
Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19.新型冠状病毒肺炎中的低白蛋白血症、凝血功能障碍和血管疾病
Circ Res. 2020 Jul 17;127(3):400-401. doi: 10.1161/CIRCRESAHA.120.317173. Epub 2020 Jun 8.
8
Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19.在 COVID-19 患者和医护人员中持续检测到 SARS-CoV-2 RNA。
J Clin Virol. 2020 Aug;129:104477. doi: 10.1016/j.jcv.2020.104477. Epub 2020 May 30.
9
Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: A retrospective study in two designated hospitals in Anhui, China.洛匹那韦/利托那韦与干扰素联合治疗可能有助于缩短 COVID-19 患者的病毒脱落持续时间:中国安徽两家定点医院的回顾性研究。
J Med Virol. 2020 Nov;92(11):2666-2674. doi: 10.1002/jmv.26127. Epub 2020 Jun 29.
10
Persistent viral shedding lasting over 60 days in a mild COVID-19 patient with ongoing positive SARS-CoV-2.一名轻度新冠病毒病患者体内持续存在新冠病毒,病毒脱落持续超过60天。
Quant Imaging Med Surg. 2020 May;10(5):1141-1144. doi: 10.21037/qims.2020.04.08.